论文部分内容阅读
目的探究丁苯酞软胶囊(恩必普)治疗急性脑梗死的临床疗效及对血清超敏C反应蛋白的影响。方法 64例急性脑梗死患者,随机分成观察组和对照组,每组32例。对照组采用常规治疗方法;观察组在常规治疗方法的基础上给予服用恩必普治疗。观察比较两组治疗效果及血清超敏C反应蛋白浓度。结果治疗后,观察组第10、20、30天的美国国立卫生研究院卒中量表(NIHSS)评分、Barthel指数、血清超敏C反应蛋白浓度均优于对照组,差异均有统计学意义(P<0.05)。结论对于急性脑梗死患者,在进行常规治疗的同时服用恩必普,能取得较好的疗效。
Objective To investigate the clinical efficacy of butylphthalide soft capsules (enbipu) in the treatment of acute cerebral infarction and its effect on serum high sensitive C-reactive protein. Methods 64 patients with acute cerebral infarction were randomly divided into observation group and control group, 32 cases in each group. The control group was treated by routine treatment; the observation group was treated with noppe on the basis of conventional treatment. The therapeutic effects and the concentrations of serum high-sensitivity C-reactive protein in the two groups were observed and compared. Results After treatment, the National Institutes of Health Stroke Scale (NIHSS) score, Barthel Index, and serum high-sensitivity C-reactive protein in the observation group were all better than those in the control group on the 10th, 20th, and 30th days P <0.05). Conclusions For patients with acute cerebral infarction, nopf should be taken at the same time as conventional treatment, and better curative effect can be obtained.